NasdaqGS - Nasdaq Real Time Price USD
Vor Biopharma Inc. (VOR)
At close: October 31 at 4:00 PM EDT
Pre-Market: 9:21 AM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
124,801.0000
126,036.0000
93,418.0000
69,018.0000
43,366.0000
Operating Income
-124,801.0000
-126,036.0000
-93,418.0000
-69,018.0000
-43,366.0000
Net Non Operating Interest Income Expense
6,707.0000
8,173.0000
1,324.0000
119.0000
29.0000
Pretax Income
-118,094.0000
-117,863.0000
-92,094.0000
-68,899.0000
-43,337.0000
Net Income Common Stockholders
-118,094.0000
-117,863.0000
-92,094.0000
-70,127.0000
-49,262.0000
Diluted NI Available to Com Stockholders
-118,094.0000
-117,863.0000
-92,094.0000
-70,127.0000
-49,262.0000
Basic EPS
-1.73
-1.75
-2.33
-2.10
-1.42
Diluted EPS
-1.73
-1.75
-2.33
-2.10
-1.42
Basic Average Shares
67,948.7340
67,191.9730
39,551.4200
33,433.2140
34,641.3600
Diluted Average Shares
67,948.7340
67,191.9730
39,551.4200
33,433.2140
34,641.3600
Total Operating Income as Reported
-124,801.0000
-126,036.0000
-93,418.0000
-69,018.0000
-43,366.0000
Total Expenses
124,801.0000
126,036.0000
93,418.0000
69,018.0000
43,366.0000
Net Income from Continuing & Discontinued Operation
-118,094.0000
-117,863.0000
-92,094.0000
-68,899.0000
-43,337.0000
Normalized Income
-118,094.0000
-117,863.0000
-92,094.0000
-68,899.0000
-43,337.0000
Interest Income
6,707.0000
8,173.0000
1,324.0000
119.0000
29.0000
Net Interest Income
6,707.0000
8,173.0000
1,324.0000
119.0000
29.0000
EBIT
-124,801.0000
-126,036.0000
-93,418.0000
-69,018.0000
-43,366.0000
EBITDA
-121,204.0000
-122,544.0000
-90,893.0000
-67,584.0000
-42,761.0000
Reconciled Depreciation
3,597.0000
3,492.0000
2,525.0000
1,434.0000
605.0000
Net Income from Continuing Operation Net Minority Interest
-118,094.0000
-117,863.0000
-92,094.0000
-68,899.0000
-43,337.0000
Normalized EBITDA
-121,204.0000
-122,544.0000
-90,893.0000
-67,584.0000
-42,761.0000
12/31/2020 - 2/5/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ELEV Elevation Oncology, Inc.
0.5743
-4.28%
CGEM Cullinan Therapeutics, Inc.
15.55
-4.13%
TNYA Tenaya Therapeutics, Inc.
1.9200
-6.34%
XLO Xilio Therapeutics, Inc.
1.2700
-7.30%
SANA Sana Biotechnology, Inc.
3.5000
-4.37%
UNCY Unicycive Therapeutics, Inc.
0.5350
+4.90%
RLYB Rallybio Corporation
1.0300
+0.98%
GOSS Gossamer Bio, Inc.
0.8780
-2.01%
IKNA Ikena Oncology, Inc.
1.7100
+0.59%
KPTI Karyopharm Therapeutics Inc.
0.9898
+17.81%